Linked page lives on the broker site, not on OpenAcquisitions.
Key points
•Pharmaceutical analytics platform with 75% gross margins and recurring subscription revenue model.
•Preferred partnership with major EHR provider reaching over 14,000 clients.
•Business model relies on subscription-based recurring revenue from existing partnerships.
Business description
Pharmaceutical analytics platform with 75% margins, recurring subscription revenue, and a preferred partnership with a major EHR provider serving over 14,000 clients.
